2012年ESC大会将于8月25日至29日在德国慕尼黑举行。本次大会聚焦心血管疾病最新基础和临床进展,涵盖基础科学、高血压、预防、护理、心力衰竭、冠心病、介入、心律失常、结构性心脏病、肺循环、影像等各个领域,预计有来自150多个国家的32000名代表参会。
2012年ESC大会将于8月25日至29日在德国慕尼黑举行。本次大会聚焦心血管疾病最新基础和临床进展,涵盖基础科学、高血压、预防、护理、心力衰竭、冠心病、介入、心律失常、结构性心脏病、肺循环、影像等各个领域,预计有来自150多个国家的32000名代表参会。
本次大会的选定的中心是“从实验室到临床”。选择创新的转化医学为中心,ESC2012期望能推动新技术快速应用于临床。
本次大会将公布或讨论2012年ESC的6个新指南和指南更新:ESC/EACTS 瓣膜疾病治疗指南、ESC心力衰竭指南、ESC ST段抬高心肌梗死指南、临床实践中心血管疾病预防指南、ESC/ACCF/AHA/WHF心肌梗死联合定义第三版和ESC心房颤动管理指南更新。
《国际循环》及国际循环网将赴慕尼黑现场全程报道会议精华及亮点内容,敬请期待!
同时,对ESC2012会议的前沿医学知识感兴趣或持有疑问观点的读者,可将您的问题和观点与我们沟通,将有机会获得ESC国际著名专家亲自“答疑解惑”的机会!联系邮箱:media@icirculation.com 有效期至2012年8月10日)。ESC官网链接<http://www.escardio.org/Pages/index.aspx>
在这次会议上将要讨论的6个新指南和指南更新
ESC/EACTS 瓣膜疾病治疗指南
The new ESC/EACTS Guidelines on the management of valve disease
Sunday 26 August - 11:00-12h30 - Room Tirana, Central Village
Provide an ’in depth’ presentation and highlight the new aspects of the?ESC Guidelines on valvular disease.
ESC心力衰竭指南
New ESC heart failure Guidelines 2012
Sunday 26 August - 16:30-18:00 - Room Munich, Central Village
This session will summarise the main changes in the new ESC Guidelines on the diagnosis and treatment of chronic and acute heart failure. The update will include discussion of pharmacological, device, surgical and other aspects of care, including patient monitoring, non-pharmacological/device therapy and end-of-life care
ESC ST段抬高心肌梗死指南
New ESC Guidelines for ST-elevation myocardial infarction
Monday 27 August - 08:30-10:00 -Room Munich,Central Village
Become familiar with the background and details of the new ESC STEMI Guidelines regarding emergency care, primary PCI, thrombolysis, adjunctive therapies
临床实践中心血管疾病预防指南
The 2012 Guidelines on cardiovascular disease prevention in clinical practice
Monday 27 August -11:00-12:30 -Room Tirana,Central Village
As prevention is a major task for cardiologists and health workers this session aims at giving the latest scientific news on CVD Prevention in Clinical Practice as recently published in the 2012 guidelines from the Joint European Societies’ Taskforce. How do I assess and manage my patients’ CVD risk, what are the available best options in lifestyle counselling and in adding drug treatment, where and by whom and how should prevention programmes be provided These are the main the questions that will be discussed in this symposium
ESC/ACCF/AHA/WHF心肌梗死联合定义第三版
Joint ESC/ACCF/AHA/WHF third universal definition of myocardial infarction
Monday 27 August -16:30-18:00 -?Room Munich,Central Village
- Learn the alterations to be included in the third edition of the universal definition of myocardial infarction
- Understand the new concept of myocardial injury compared with myocardial infarction
- Understand the differences between the various subtypes of myocardial infarction
- Clarify the confusing state of knowledge surrounding post PCI troponin elevations
ESC心房颤动管理指南更新
Update of the ESC Guidelines on the management of atrial fibrillation
Tuesday 28 August - 08:30-10:00 - Room Munich, Central Village
- Understand the updates to the 2010 ESC Guidelines on the management of atrial fibrillation
- Appreciate the role of new anticoagulants, left atrial occlusion/excision and risk stratification for stroke prevention in atrial fibrillation
- Realise the revised use of dronedarone for paroxysmal and persistent atrial fibrillation
- Comprehend the use of vernakalant for pharmacological termination of recent onset atrial fibrillation